Comparison of Subcutaneous Apomorphine Versus Dispersible Madopar Latency and Effect Duration in Parkinsonʼs Disease Patients
- 1 April 1997
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Clinical Neuropharmacology
- Vol. 20 (2) , 165-167
- https://doi.org/10.1097/00002826-199704000-00008
Abstract
Twelve parkinsonian patients with severely fluctuating symptoms were given a single dose of apomorphine or Dispersible Madopar on 2 consecutive days, to confirm the latter drug's usefulness in "off" period rescue. According to our results, apomorphine proved faster in reverting "off" periods and should still be regarded as the drug of choice for this treatment modality.Keywords
This publication has 0 references indexed in Scilit: